Central sleep apnea

Breathing-Reiated Sieep Disorders. The breathing-related sleep disorders include obstructive sleep apnea, central sleep apnea, and alveolar hypoventilation. Of these three, obstructive sleep apnea is by far the most common. The patient with sleep apnea usually breathes normally when awake and only stops breathing while asleep. Occasional episodes of apnea are normal, but five or more episodes of apnea per hour are usually considered diagnostic of the disorder. [Pg.264]

Wise MG, Fisher JG, de la Pena AM. 1983. Trichloroethane (TCE) and central sleep apnea a case study. [Pg.298]

Central sleep apnea (CSA less than 10% of all apneas) is characterized by repeated episodes of apnea caused by temporary loss of respiratory effort during sleep. It may be caused by autonomic nervous system lesions, neurologic diseases, high altitudes, and congestive heart failure. [Pg.832]

Nonpeptide receptors Adenosine Aj Human cDNA Cardiac arrhythmia, asthma, myocardial ischemia, obesity, pain, renal disease, sleep apnea, stroke, cancer, inflammation, glaucoma, cystic fibrosis, Alzheimer s disease, Parkinson s disease Bradycardia, lipolysis inhibition, reduction of glomerular filtration and natriuresis, tubero-glomerular feedback, antinociception, renal vasodilatation-constriction, reduction of central cholinergic and noradrenergic nerve activity, presynaptic inhibition of excitatory neuro transmission... [Pg.122]

Caffeine and theophylline are more active on the central nervous system, while theobromine is much less active. Caffeine and theophylline also appear to stimulate the respiratory centers, making them useful in the treatment of infants who stop breathing for extended periods of time (sleep apnea), which can lead to sudden infant death. [Pg.57]

Bradley TD, Floras IS. Sleep apnea and heart failure Part II central sleep apnea. Circulation. Apr 8 2003 107(13) 1822-1826. [Pg.142]

Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. Oct 1999 160(4) 1101-1106. [Pg.142]

Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N EnglJ Med. Nov 10 2005 353(19) 2025-2033. [Pg.142]

Naughton MT, Benard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. Aug 1995 152(2) 473-479. [Pg.142]

Unlabeled Uses Sleep apnea, congenital central hypoventilation syndrome, obesity-hypoventilation syndrome, postanesthetic respiratory depression, shivering... [Pg.396]

Central sleep apnea involving lack of diaphragmatic effort... [Pg.227]

Bonnet MH, Dexter JR, Arand DL. The effect of triazolam on arousal and respiration in central sleep apnea patients. Sieep 1990 13 31-41. [Pg.308]

Neuropharmacology of obstructive sleep apnea and central apnea... [Pg.22]

Carley DW, Radulovacki M (1999) Role of peripheral serotonin in the regulation of central sleep apneas in rats. Chest 115 1397-1401... [Pg.36]

Franklin KA, Eriksson P, Sahlin C, Lundgren R (1997) Reversal of central sleep apnea with oxygen. Chest 111 163-169... [Pg.42]

Naughton MT, Benard DC, Rutherford R, Bradley TD (1994) Effect of continuous positive airway pressure on central sleep apnea and nocturnal PC02 in heart failure. Am JRespir Crit Care Med 150(6 Pt 1) 1598-1604... [Pg.42]

Gold AR, Bleecker ER, Smith PL (1985) A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am Rev Respir Dis 132 220-223... [Pg.170]

Javaheri S (2005) Central sleep apnea in congestive heart failure prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 26 44—55... [Pg.170]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...